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Crystal Structures of the Type III Effector
Protein AvrPphF and Its Chaperone Reveal
Residues Required for Plant Pathogenesis
nizes the virulence activity of type III effectors (Axtell
and Staskawicz, 2003; Mackey et al., 2002, 2003; Shao
et al., 2003). These observations support a general
model in which indirect recognition of the action of
pathogen virulence factors initiates successful plant im-
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functions as a Rho-GAP (GTPase activating protein);
YopT is a cysteine protease that targets Rho family
GTPases; and YopO/YpkA is a Ser/Thr kinase (Cornelis,Summary
2002). Similarly, the intracellular pathogen Salmonella
delivers two sets of type III effectors during distinctThe avrPphF locus from Pseudomonas syringae pv.
phaseolicola, the causative agent of bean halo-blight phases of its infection cycle (Galan, 2001; Hansen-
Wester and Hensel, 2001). The first set is required todisease, encodes proteins which either enhance viru-
lence on susceptible hosts or elicit defense responses reprogram eukaryotic actin to allow endocytosis of Sal-
monella, while the second set prevents endocytic vacu-on hosts carrying the R1 resistance gene. Here we
present the crystal structures of the two proteins from oles from fusing with lysosomal vacuoles, thereby facili-
tating retrograde bacterial transport.the avrPphF operon. The structure of AvrPphF ORF1
is strikingly reminiscent of type III chaperones from In contrast, functions for type III effectors from plant
pathogens remain poorly characterized. Recent ge-bacterial pathogens of animals, indicating structural
conservation of these specialized chaperones, despite nome-wide analyses for proteins that might be sub-
strates for the type III secretion system of the planthigh sequence divergence. The AvrPphF ORF2 ef-
fector adopts a novel “mushroom”-like structure con- pathogen Pseudomonas syringae pathovar tomato (Pst)
DC3000 revealed 50 confirmed or predicted type IIItaining “head” and “stalk” subdomains. The head sub-
domain possesses limited structural homology to the effectors (Boch et al., 2002; Collmer et al., 2002; Fouts
et al., 2002; Greenberg and Vinatzer, 2003; Guttman etcatalytic domain of bacterial ADP-ribosyltransferases
(ADP-RTs), though no ADP-RT activity was detected al., 2002; Petnicki-Ocwieja et al., 2002; Zwiesler-Vollick
et al., 2002). Furthermore, several type III effectors offor AvrPphF ORF2 in standard assays. Nonetheless,
this structural similarity identified two clusters of con- P. syringae increase virulence on genetically susceptible
hosts (Chang et al., 2000; Chen et al., 2000; Lorangserved surface-exposed residues important for both
virulence mediated by AvrPphF ORF2 and recognition and Keen, 1995; Nimchuk et al., 2001; Ritter and Dangl,
1995). However, despite increasing efforts, biochemicalof this effector by bean plants expressing the R1 resis-
tance gene. functions have been assigned to a paltry few P. syringae
type III effectors (Axtell et al., 2003; Espinosa et al., 2003;
Shao et al., 2002). Consequently, understanding theIntroduction
function of type III effector proteins in virulence and in
triggering host disease resistance is currently a majorMany Gram-negative bacterial pathogens of either plants
or animals use an evolutionarily conserved type III secre- goal in the study of plant pathology.
In response to this dearth of functional data and thetion system (TTSS) to deliver proteins, termed type III
mounting realization that conventional biochemical andeffectors, directly into host cells. Efficient secretion of
genetic techniques do not readily yield functional as-a subset of type III effectors requires type III chaperones,
signments for type III effectors, we initiated a structuralwhich are small acidic proteins that typically bind to a
approach to further characterize P. syringae type III ef-single effector transcribed from the same operon (Parsot
fectors in order to gain insight into their mechanisms ofet al., 2003). Once inside the host cell, a number of these
action. Here, we present the crystal structures of thetype III effectors manipulate signaling pathways in order
two gene products (ORF1 and ORF2) of the avrPphFto inhibit host defense mechanisms and aid pathogen
locus. This locus resides in a pathogenicity island oncolonization (Jin et al., 2003; Staskawicz et al., 2001).
the naturally occurring plasmid pAV511 of the beanRecent findings suggest that the plant immune system,
pathogen P. syringae pv. phaseolicola (Jackson et al.,governed by plant disease resistance (R ) genes, recog-
1999; Tsiamis et al., 2000). AvrPphF ORF1 and ORF2
are both required for maximal virulence of P. syringae*Correspondence: dangl@email.unc.edu (J.L.D.); sondek@med.unc.
on susceptible plants, as well as for the initiation ofedu (J.S.)
8 These authors contributed equally to this work. specific host immune responses on genetically resistant
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Figure 1. Stereoview of Experimental Elec-
tron Density for AvrPphF ORF1
The region highlighted is along the dimer in-
terface mediated by 2 helices, and the two
participating monomers are colored blue and
red for clarity. The map shown is contoured
at 0.8  using phases derived from multiple
anomolous wavelength data at 3.0 A˚ reso-
lution.
plants (Tsiamis et al., 2000). More specifically, on sus- [Stebbins and Galan, 2001]), enterohemorrhagic E. coli
CesT (PDB code: 1K3E [Luo et al., 2001]), and Salmo-ceptible bean cultivars (inbred strains) that lack the R1
resistance gene, such as Tendergreen, AvrPphF en- nella enterica SigE (PDB code: 1K3S [Luo et al., 2001]),
despite low sequence similarity (% identity betweenhances pathogen growth and is thus a virulence factor.
Conversely, on cultivars possessing the R1 resistance AvrPphF ORF1 and these four chaperones varies from
15% for SicE and SigE to 8% for SicP and CesT). Likegene, such as Red Mexican, AvrPphF is recognized by
the plant immune system and is therefore experimentally other type III chaperones, AvrPphF ORF1 adopts an
------- topology with a significant negativelydefined as an avirulence factor.
The crystal structure of AvrPphF ORF1 confirms its charged electrostatic surface and two pairs of hy-
drophobic patches. In particular, the fold of SycE, thepredicted role as a type III chaperone; in contrast, the
structure of AvrPphF ORF2 is novel. The structure of chaperone of the Yersinia effector YopE, is virtually iden-
tical to that of AvrPphF ORF1 (Figure 2A). One hundredAvrPphF ORF2 was used to identify surface residues
required for both the virulence and avirulence functions and six C residues of AvrPphF ORF1 and SycE can be
superimposed with a root-mean-square deviation (rmsd)of AvrPphF. These results validate a structure-based
effort to identify key functional features of P. syringae of 2.5 A˚ calculated using the DALI server (Holm and
Sander, 1993). The structural similarity between AvrPphFtype III effectors and highlight the importance of struc-
tural analyses to complement biochemical and genetic ORF1 and other type III chaperones suggests the preser-
vation of common functions through structural conser-techniques in order to maximize the deduction of func-
tional information. vation.
Currently, there are no published cocrystal structures
of a type III chaperone with a full-length effector. How-Results
ever, there are two crystal structures of type III chaper-
ones bound to N-terminal fragments of their cognateThe AvrPphF ORF1 Structure Indicates
Universality among Type III Effector Chaperones type III effectors. These are the structures of SicP bound
to its effector SptP (Stebbins and Galan, 2001) and SycEThe crystal structure of AvrPphF ORF1 was determined
to a resolution of 3 A˚ using multiwavelength anomalous in complex with its cognate effector YopE (Birtalan et
al., 2002). The SicP/SptP and SycE/YopE interactionsdispersion (Figures 1 and 2; Table 1). There are four
molecules per asymmetric unit. However, one dimer in- are mediated predominantly by hydrophobic interac-
tions located at two distinct patches on the chaperoneterface mediated by a central pair of symmetrical helices
(2) predominates (total buried surface area of 3548 A˚2) homodimer surface (Figure 2B). The first patch lies in a
concavity that accommodates an  helix of the respec-and resembles the extensive dimer interface found in
structures of other type III chaperones (Parsot et al., tive effector (helix binding groove, or patch 1), while the
second hydrophobic patch binds to a  strand of the2003). Therefore, it is most likely that this dimeric form
of AvrPphF ORF1 is the biologically relevant unit. This effector (patch 2) (Stebbins and Galan, 2001; Birtalan et
al., 2002) (see Figure 2B). The surface of the AvrPphFinterpretation is supported by the fact that AvrPphF
ORF1 is dimeric in solution based upon gel exclusion ORF1 dimer displays similar regions; however, the chemi-
cal nature of these patches is not as highly hydrophobicchromatography (data not shown). Like other dimeric
type III chaperones, the 2 helix of AvrPphF ORF1 pre- as SycE and SicP. Interestingly, there are two distinct
hydrophobic patches on the AvrPphF ORF1 homodimerdominantly contributes intermolecular interactions within
the dimer (Figure 1). Centered within the dimeric inter- surface. The first hydrophobic patch is located near
one end of the aforementioned putative helix bindingface, Cys67 of the 2 helix forms an intermolecular disul-
fide bond. However, this cysteine is not conserved grooves and along the dimer interface, and includes
a shallow depression containing the residues Pro83,among alleles of AvrPphF ORF1 and most likely is not
critical for maintaining the dimeric form of AvrPphF Phe84, and Phe85 (Figure 2B), which are well conserved
among AvrPphF ORF1 alleles (Figure 2C). The secondORF1 (Figure 2C).
Structural comparisons using the program DALI (Holm hydrophobic patch of AvrPphF ORF1 (patch 2) is formed
by conserved residues Phe7, Pro21, Phe23, Tyr33, andand Sander, 1993) report highly significant Z scores of
10–12 between AvrPphF ORF1 and other type III chap- Phe5 and is adjacent to the helix binding groove (Figures
2B and 2C). Therefore, if the interaction of AvrPphFerones, including Yersinia pseudotuberculosis SycE (PDB
code: 1JYA [Birtalan and Ghosh, 2001; Birtalan et al., ORF1 and ORF2 is mediated by mainly hydrophobic
interactions, the location of candidate surfaces on the2002]), Salmonella typhimurium SicP (PDB code: 1JYO
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Figure 2. Structural Similarity between
AvrPphF ORF1 and Yersinia pseudotubercu-
losis SycE
(A) Ribbon diagrams emphasize the structural
similarity of AvrPphF ORF1 (left) to the chap-
erone SycE (right; PDB code: 1L2W [Birtalan
et al., 2002]). The major helices (1–3) of
each monomer are colored to emphasize their
similar tertiary and quaternary structures.
(B) AvrPphF ORF1 shares surfaces features
with SycE required for binding type III ef-
fectors. MOLCAD surfaces of AvrPphF ORF1
and SycE were generated using the program
SYBYL version 6.9.1 (www.tripos.com) and
were colored by hydrophobic potential (Ghose
et al., 1998; Viswandam et al., 1989) over a
range of 0.25–0.05, where blue to green to
brown represents the spectrum from hydro-
philic to hydrophobic regions. The two hy-
drophobic effector binding regions on SycE
(Birtalan and Ghosh, 2001; Birtalan et al.,
2002) are circled and labeled, as are the cor-
responding surfaces on AvrPphF ORF1. Note
that patches one and two arise from mole-
cules 1 and 2 of the dimer, respectively, and
that a rotation of 180 about the vertical would
result in display of the same surfaces but on
opposite molecules. Additional conserved
residues on two additional hydrophobic re-
gions on the AvrPphF ORF1 surface are also
labeled.
(C) Multiple sequence alignment of AvrPphF
ORF1 alleles with SicP and SycE. Alignment
of the four AvrPphF ORF1 alleles was per-
formed with ClustalX (Jeanmougin et al., 1998),
while alignment of AvrPphF ORF1 from P. syr-
ingae pv. phaseolicola (ORF1_Pph) with SicP
and SycE was done using the structural align-
ment output from DALI. Positions of helices
(red cylinders) and  strands (blue arrows) in
the AvrPphF ORF1 structure are shown.
Chaperone residues with buried surface areas of 10 A˚2 due to effector binding in the SicP/SptP or SycE/YopE complexes are highlighted
with blue or yellow circles, respectively, while residues of AvrPphF ORF1 associated with the additional hydrophobic surfaces in Figure 2B
are highlighted with magenta circles. Buried surface area was calculated using the program NACCESS (Hubbard and Thornton, 1993).
Sequences used in the alignment are from P. syringae pv. phaseolicola (ORF1_Pph), P. syringae pv. glycinea (ORF1_Pgy [J.H.C., unpublished
data]), P syringae pv. delphinii (ORF1_Pdp, GenBank accession number AAP23119.1), P. syringae pv. tomato strain DC3000 (ORF1_DC3000,
AA054047.1), Yersinia pseudotuberculosis SycE (1L2W), and Salmonella typhimurium SicP (1JYO).
ORF1 dimer suggests a different mode of interaction  sheets (1 and 6; 2 and 9/9) supported by 2
than that observed for SicP/SptP and SycE/YopE. form the dome of the head.
In addition, we note the conservation of Glu116 among Alleles of AvrPphF ORF2 have no significant sequence
AvrPphF ORF1 alleles, which in SicP and SycE forms a similarity to other proteins (data not shown). However,
salt bridge with a conserved arginine in the correspond- the head subdomain of AvrPphF ORF2 possesses weak
ing virulence factors. This observation supports conser- structural similarity with the catalytic portion of a number
vation of some specificity in chaperone/effector interac- of ADP-ribosyltransferase (ADP-RT) toxins (Figure 4).
tions. For example, structural comparisons using the DALI
server indicate the strongest structural similarity (Z
score  4.3 over 79 C atoms, rmsd of 2.9 A˚, 10%The Structure of AvrPphF ORF2 Is Novel
sequence identity) between the head subdomain andThe structure of AvrPphF ORF2 (Figure 3; Table 1) was
the catalytic domain of diphtheria toxin (PDB code:determined by multiple isomorphous replacement with
1DDT [Bennett et al., 1994]) (Figures 4C and 4D). Specifi-anomalous scattering using crystals soaked in high con-
cally, AvrPphF ORF2 strands 1, 5, 6, 7, 8, and 9centrations of CsCl (Dauter et al., 2000, 2001). AvrPphF
superimpose in whole or in part with diphtheria strandsORF2 forms an elongated structure (60 A˚ 	 20–35 A˚)
CB2, CB3, CB4, CB6, CB7, and CB8, respectively (usingsomewhat reminiscent of a mushroom that can be di-
the nomenclature of Bennett et al. [1994]) (Figure 4D).vided into “stalk” and “head” subdomains (Figures 3
Despite this structural relatedness, AvrPphF ORF2 didand 4). The stalk subdomain is composed of the N-ter-
not possess NAD glycohydrolase activity using an in vitrominal helix (1) and  strands 3-4. An antiparallel 
fluorescence assay which monitors the increase insheet (5, 7-8) forms the base of the head subdomain
that interacts with the stalk. A pair of twisted antiparallel quantum yield that occurs when etheno-NAD (Sigma-
Structure
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Table 1. Data Collection and Refinement Statistics
AvrPphF ORF1 AvrPphF ORF2
Structure
Data set 
1 
2 
3 Native CsCl
Data Collection
Wavelength (A˚) 0.97925 0.97936 0.97167 1.5418 1.5418
Resolution (A˚) 20.0–3.0 20.0–3.0 20.0–3.1 20.0–2.0 20.0–2.4
Total observations 139,782 140,056 140,110 58,578 118,527
Unique reflections 18,973 19,032 19,032 16,442 9,639
Completeness (%) 100.0 (100.0)a 100.0 (100.0) 100.0 (100.0) 99.8 (99.1) 99.9 (98.7)
I/b 26.9 (7.7) 23.8 (4.8) 20.5 (3.4) 18.9 (6.1) 29.0 (4.5)
Rsymc 9.6 (25.7) 9.6 (44.5) 10.3 (63.0) 5.4 (23.3) 10.6 (30.9)
Refinement and Model Statistics
Resolution (A˚) 20–3.0 20–2.0
Mean figure of meritd 0.628/0.776 0.425/0.796
Reflections 17,577/893 15,610/798
(working/test)
Rworke (%) 24.1 22.5
Rfreef (%) 28.9 24.1
Mean B factor 44.1 33.6
(overall, A˚2)
Wilson B factor (A˚2) 72.4 18.6
Rms deviations
Bond lengths (A˚) 0.009 0.005
Bond angles () 1.4 1.3
Ramachandran plot
% in most favored 80.6 88.5
regions
% in additional 17.7 11.5
allowed regions
% in disallowed 0.0 0.0
regions
a Values in parentheses refer to the highest resolution shell.
b I/  mean signal to noise, where I is the integrated intensity of a measured reflection, and  is the estimated error in measurement.
c Rsym  100 	 |1  I/I, where I is the integrated intensity of each measured reflection.
d For AvrPphF ORF1 phase determination, these represent FOM values before and after solvent flattening with DM (CCP4, 1994), both at 3 A˚.
For AvrPphF ORF2, these FOM values represent phases to 2.4 A˚ before and after using the solvent-flattening routine in SHELXE (Schneider
and Sheldrick, 2002).
e Rwork|Fo  Fc|/Fo, where Fo and Fc are defined as the observed and calculated structure factor amplitudes.
f Rfree is calculated as defined by Rwork using test set reflections (5% of the total).
Aldrich) is hydrolyzed (Beattie and Merrill, 1999). Simi- ADP-RT activity, we used the structural homology to
diphtheria toxin and amino acid conservation acrosslarly, purified AvrPphF ORF2 had no ADP-RT activity
in an assay that examined labeling of proteins in an multiple alleles of AvrPphF ORF2 as predictors of resi-
dues required for function.Arabidopsis cell extract containing radiolabeled NAD
(Coburn et al., 1989), even if supplemented with its cog- For instance, in diphtheria toxin, amino acids His21
and Glu148 correspond to critical catalytic residues re-nate chaperone AvrPphF ORF1 (data not shown). How-
ever, both activities were readily demonstrated with the quired for ADP-RT activity (Takada et al., 1995). In ADP-
RTs, His21 corresponds to a conserved basic residuecatalytic domain of exotoxin A of Pseudomonas aerugi-
nosa, a known ADP-RT (Iglewski and Kabat, 1975). Simi- which hydrogen bonds to the adenosine ribose, while
larly, crystals of AvrPphF ORF2 either grown with NAD Glu148 corresponds to an absolutely conserved cata-
(10 mM) or soaked with similar concentrations of NAD lytic residue which extracts a proton from the 2 hydroxyl
prior to data collection showed no electron density con- of the nicotinamide-linked ribose. In AvrPphF ORF2,
sistent with bound NAD. Manually docking of NAD into Arg72 and Asp174 are spatially equivalent to His21 and
the putative active site of AvrPphF ORF2 suggests that Glu148, respectively, from diphtheria toxin (Figures 4A
a  strand (2), with no equivalent in diphtheria toxin, and 4C). This suggests a potential for these residues in
sterically blocks binding of NAD. mediating the virulence activity of AvrPphF ORF2. We
additionally identified residues conserved between al-
leles of AvrPphF ORF2 that lie on exposed surfaces ofStructure-Based Identification of Key Functional
the molecule. Two surface regions on opposing sidesResidues in AvrPphF ORF2
of the molecule harbor residues conserved between theStructural conservation of catalytic residues between
four AvrPphF ORF2 alleles (Figure 5). The first surfacedifferent enzymes has been described (e.g., for transglu-
encompasses the region that shares structural homol-taminases and cysteine proteases [Makarova et al.,
1999]). Therefore, despite the lack of AvrPphF ORF2 ogy to the NAD binding site of ADP-RT toxins and forms
The Type III Effector AvrPphF and Its Chaperone
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Figure 3. The Structure of the AvrPphF ORF2 Type III Effector Is Novel
(A) Stereoview of experimental electron density for AvrPphF ORF2 derived from MIRAS phases. The displayed region (pocket A, see text)
contains a large number of conserved residues among alleles of AvrPphF ORF2 including Arg72 (blue), Ser90 (green), and Asp174 (red) chosen
for site-directed mutagenesis. The experimental electron density map is contoured at 1.0  at 2.0 A˚ resolution.
(B) Stereoview of the backbone trace of AvrPphF ORF2. Beginning at residue 30, every 20th residue is labeled and marked with a black
sphere, helices are red, and  strands are blue. Disordered regions are indicated with dotted lines.
a groove in the head subdomain. We termed this “pocket could be involved in catalytic activities. Using these
combined criteria, we mutated Ser90 in addition to Arg72A.” Pocket A possesses fourteen residues that are abso-
lutely conserved between AvrPphF ORF2 alleles includ- and Asp174 in pocket A and also chose His97 and Glu98
for mutagenesis in pocket B.ing the exposed Arg72 and Asp174. On the opposite side
of the protein, a second conserved surface is located at Wild-type and mutated versions of AvrPphF ORF2
were fused to a C-terminal HA-epitope tag, cloned intothe interface between the head and stalk (pocket B).
Conserved residues on these two surfaces are both hy- the expression vector pDSK600 (Keen et al., 1988), and
transformed into the RW60 strain of P. syringae pv.drophilic and hydrophobic. However, hydrophilic resi-
dues were favored for mutagenesis due to their role in phaseolicola (Pph). Pph RW60 is cured of the pAV511
plasmid that normally harbors the avrPphF ORF1 andhydrogen bonding and the higher probability that they
Structure
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Figure 4. Structural Similarity between
AvrPphF ORF2 and an ADP-Ribosyltrans-
ferase
(A) Ribbon trace of AvrPphF ORF2 in two ori-
entations related by 110 and emphasizing
the stalk and head subdomains. Of the helical
segments (red), only two (helices A and B)
extend for more than one turn and have been
noted.  strands are blue and dashed lines
represent disordered regions at the N terminus,
residues 147–153, and residues 177–180.
(B) Topological diagram of the AvrPphF ORF2
fold highlighting the three sets of  strands
(1and 6; 2 and 9,9; 5, 7, and 8) ap-
proximately arranged in mutually supporting
triangles and composing the majority of the
head subdomain.
(C) Structural similarity of AvrPphF ORF2 and
diphtheria toxin. Shown is a ribbon diagram
of the ADP-ribosyltransferase domain of diph-
theria toxin highlighting the critical catalytic
residues, His21 and Glu148. The functionally
similar Arg72 and Asp174 are located at
equivalent positions in the AvrPphF ORF2
structure (upper left panel in [A]). The dis-
tance between the residues on both struc-
tures is indicated in A˚. Strands are labeled
according to the nomenclature of Bennett et
al. (1994).
(D) Superposition of AvrPphF ORF2 with the
catalytic domain of diphtheria toxin. A ribbon
diagram of these two structures superim-
posed using the structurally aligned residues
listed from DALI is shown. The orientation of
these two molecules is identical to that shown
in Figures 3A and 3C. The N- and C termini
of each molecule are labeled.
ORF2 operon (Tsiamis et al., 2000). ORF1 was cloned relative to RW60 carrying an empty vector. Western blot
analysis confirmed that each protein was the correctinto the vector pBBR1 MCS-2 (Kovach et al., 1995) and
also transformed into each strain. Pathogenic growth of molecular weight and expressed to a similar level (Fig-
ure 6C).these bacteria was monitored on the susceptible Tender-
green bean cultivar. RW60 carrying the empty pDSK600 Many type III effectors from plant pathogenic bacteria
are also the determinants recognized by the plant’s im-vector and expressing AvrPphF ORF1 grew approxi-
mately 20-fold over 2 days (Figure 6A). The presence of mune system (see Introduction). Therefore, we deter-
mined if amino acids important for the virulence functionwild-type AvrPphF ORF2 in this strain increased patho-
gen growth by an additional 10-fold, reflecting the of AvrPphF ORF2 are also required for its ability to trig-
ger a specific host disease resistance response. GrowthAvrPphF ORF2 virulence function (Tsiamis et al., 2000).
Mutation of either Arg72 (R72A) or Asp174 (D174A) in of the Pph RW60 strains expressing wild-type and mu-
tant AvrPphF ORF2 proteins was examined on the beanpocket A eliminated the virulence function of AvrPphF
ORF2. Mutation of Ser90 (S90A) did not eliminate the cultivar Red Mexican, which expresses the R1 disease
resistance gene (Figure 6B). Virulent Pph RW60 carryingvirulence function, though slight losses in virulence were
observed in some experiments (data not shown). Last, an empty pDSK600 vector and expressing AvrPphF
ORF1 grew robustly over 3 days on this cultivar. Expres-mutation of His97 (H97A) or Glu98 (E98A) had an inter-
mediate effect, increasing pathogen growth by 5-fold sion of wild-type AvrPphF ORF2 significantly reduced
The Type III Effector AvrPphF and Its Chaperone
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Figure 5. Conserved Surface Residues of
AvrPphF ORF2
(A) There are two highly conserved surface
patches in alleles of AvrPphF ORF2. Shown
are two surface representations of AvrPphF
ORF2 related by an 110 rotation about the
vertical axis, with residues identical in at least
three of the four AvrPphF alleles highlighted
yellow. Enumerated residues are essentially
invariant among the alleles and were mutated
in this study. The left orientation highlights
pocket A, the right orientation highlights
pocket B, and the associated ribbon dia-
grams (insets) indicate the underlying struc-
ture for the respective surfaces. Orientations
shown in this figure are identical to those in
Figure 4.
(B) Amino acid sequence alignment of the
four alleles of AvrPphF ORF2. Helical seg-
ments (red cylinders) and  strands (blue
arrows) in AvrPphF OFR2 are shown. Resi-
dues targeted for mutation are highlighted
with green (pocket A) and yellow (pocket B)
circles. Sequences with associated GenBank
accession numbers used in the alignment are
from P. syringae pv. phaseolicola (ORF2_Pph,
AAF67149.1), P. syringae pv. delphinii (ORF2_
Pdp, AAP23118.1), P. syringae pv. tomato
strain DC3000 (ORF2_DC3000, AA054046.1),
and Ralstonia solanacearum (ORF2_Ralst,
NP_522383.1).
pathogen growth, reflecting recognition of Pph RW60 pathogen. Interestingly, despite low sequence similarity
by the bean R1 disease resistance gene (Tsiamis et al., (8%–14%), the structure is very similar to that of chaper-
2000). In parallel to our observations of the AvrPphF ones from the animal pathogens Yersinia, enteropatho-
ORF2 virulence function, the pocket A mutations R72A genic E. coli, and Salmonella, suggesting that chaperones
and D174A abolished the resistance response, S90A did of plant and animal pathogens use similar mechanisms
not, and pocket B mutations, H97A and E98A, had an to promote the secretion of type III effectors. The identifi-
intermediate effect. Therefore, AvrPphF ORF2 amino cation of AvrPphF ORF1 as a type III chaperone is not
acids important for its virulence activity are also required surprising, for two reasons: First, despite low sequence
for optimal recognition of the presence of this type III conservation, the protein-threading server 3D-PSSM
effector by the bean R1 gene product. (Kelley et al., 2000) identified the known type III effectors
To exclude the possibility that mutation of Arg77 or SycE and SigE as likely structural homologs. Second,
Asp174 eliminated AvrPphF ORF2 functions by disrup- the recently sequenced tomato Pst DC3000 genome
tion of proper protein folding or favoring aggregation, contains homologs of both AvrPphF ORF1 and AvrPphF
we expressed both mutant proteins in E. coli. We found ORF2 within the same operon. The DC3000 homolog
that these proteins were soluble when prepared from ShcF, which shares 50% identity in protein sequence
E. coli cell extracts and that the resulting proteins were to AvrPphF ORF1 (Figure 2C), was designated a type III
monomeric on gel filtration columns (Figure 6D). Further- chaperone for the AvrPphF ORF2 homolog HopPtoF
more, wild-type and mutant proteins yielded very similar prior to determination of the AvrPphF ORF1 structure
circular dichroism spectra (Figure 6E), indicating the and has been recently demonstrated to function as
similarity of their folds. chaperone for HopPtoF in vivo (Shan et al., 2004).
The cocrystal structures of SicP/SptP and SycE/YopE
have shown that chaperones bind to regions of typeDiscussion
III effectors that contain secondary, but little tertiary,
structure and have highlighted the effector wrappingThe crystal structures of AvrPphF ORF1 and AvrPphF
around chaperone dimers (Birtalan et al., 2002; StebbinsORF2 represent the first structures of a type III chaper-
one and its corresponding type III effector from a plant and Galan, 2001). From these structures, it has been
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Figure 6. Conserved Surface Residues of AvrPphF ORF2 Are Required for Both Virulence and Avirulence Activities
(A) Growth of P. syringae pv. phaseolicola strain RW60 expressing wild-type and mutant versions of AvrPphF-HA on the Tendergreen bean
cultivar, where AvrPphF acts as a virulence factor. White and gray bars represent the bacterial populations immediately post inoculation (day
0) and 2 days post inoculation. () represents the negative control strain carrying an empty pDSK600 vector. Error bars represent the standard
error of the mean of three samples. Results are representative of four independent experiments. Asterisks indicate values that are significantly
different from the empty vector as determined by one-way ANOVA (*p  0.05). All strains also carry a second plasmid expressing avrPphF
ORF1.
(B) Growth of P. syringae pv. phaseolicola strain RW60 expressing the wild-type and mutant versions of AvrPphF-HA on the Red Mexican
bean cultivar where AvrPphF acts as an avirulence factor triggering disease resistance via the bean R1 disease resistance gene. White and
gray bars represent the bacterial populations immediately post inoculation (day 0) and 3 days post inoculation. Other symbols are described
in the previous panel. All strains also carry a second plasmid expressing avrPphF ORF1.
(C) Western blot analysis using anti-HA antibodies of soluble protein from P. syringae RW60 expressing the various AvrPphF proteins. 10 g
of soluble protein was loaded in each lane.
(D) Gel filtration of wild-type AvrPphF ORF2 and R72A and D174A mutant proteins. The three proteins migrate with virtually identical mobilities
on a Sephacryl S200 column (Pharmacia) with an apparent molecular weight of25 kDa based upon the elution of molecular weight standards.
In comparison, the calculated molecular weight is 22 kDa for the wild-type and mutant proteins.
(E) Circular dichroism spectra of wild-type AvrPphF ORF2 and R72A and D174A mutant proteins. Mean molar ellipticity is plotted as a function
of wavelength, and the spectra of the wild-type and mutant proteins are found to be virtually identical. The spectrum of the wild-type protein
was curve-fit using the program CONTINLL (Provencher and Glockner, 1981) and found to contain a similar component of secondary structural
elements as calculated from the coordinates of the structure and listed beneath the spectra.
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proposed that chaperones may contribute to effector activity of AvrPphF ORF2. We experimentally confirmed
these predictions for two of these residues, Arg72 andsecretion by maintaining them in partially unfolded, se-
cretion-competent states (Stebbins and Galan, 2001). Asp174. In addition, when these mutant proteins were
purified upon expression in E. coli, they were soluble,Alternatively, it has been proposed that the three-dimen-
sional structure of the chaperone/effector complex may monomeric, and had circular dichroism spectra identical
to wild-type protein, indicating that these mutations didprovide a translocation signal for secretion (Birtalan et
al., 2002). Consistent with either scenario, and unlike not affect the solubility, aggregation state, or folding of
AvrPphF ORF2.other chaperones such as Gro/EL and DnaK/Hsp70 pro-
tein families, type III chaperones are not believed to be Another structurally based criterion that was success-
ful in predicting residues important for virulence activityinvolved in folding of the effector, since identical Rho-
GAP activities are found for YopE alone or in complex was the identification of clusters of conserved amino
acids with exposed side chains. Residues conservedwith its chaperone SycE (Birtalan et al., 2002). In addi-
tion, the E. coli effector Tir has an identical affinity for the among the AvrPphF ORF2 alleles clustered in two large
cavities on the effector, which we identified as pocketintimin receptor alone and in complex with its chaperone
CesT (Luo et al., 2001). Recently, the E. coli chaperone A and pocket B. These two conserved regions are lo-
cated on opposite sides of the molecule and possessCesT has been demonstrated to interact with the TTSS
ATPase component, EscN (Gauthier and Finlay, 2003), different characteristics. Pocket A is located in the
“head” of the protein and forms part of a groove runningindicating that type III chaperones may specifically inter-
act with components of the TTSS apparatus, allowing down the length of the molecule. Pocket B is less de-
pressed than pocket A and lies at the interface betweenfor efficient transport of the effector to the type III pilus.
AvrPphF ORF1 possesses two hydrophobic patches the head and the stalk subdomains. Based on mutational
data, both surfaces are necessary for virulence facili-similar to those that mediate interactions of SycE and
SicP with their corresponding effectors (Figure 2B). tated by AvrPphF ORF2 as well as its ability to trigger
host disease resistance mediated by the bean R1 gene.However, the novel arrangement of these patches on
the surface of the ORF1 molecule may indicate a novel The mutations are beyond the first 60 amino acids of
the N terminus typically required for type III effectormode of chaperone/effector interaction for AvrPphF.
Furthermore, type III chaperones bind to an 60–100 translocation by plant and animal pathogens, and are
therefore unlikely to affect delivery by the type III secre-residue region of the effector in a partially unfolded con-
formation (Birtalan et al., 2002; Stebbins and Galan, tion system (Anderson et al., 1999; Mudgett et al., 2000;
Page and Parsot, 2002). Similarly, previous mutagenesis2001). In YopE and SptP, chaperone binding regions lie
N-terminal to GAP domains (Evdokimov et al., 2002; studies of the type III effector AvrPto revealed that out
of 21 point mutations, only one affected translocationStebbins and Galan, 2000), and since these regions have
been removed during structure determination of their (Chang et al., 2001). Furthermore, this mutation resulted
in an amino acid change from a histidine to a proline, acorresponding GAP domains, they may already exist in
a partially unfolded conformation prior to chaperone mutation that could potentially have deleterious struc-
tural effects (Chang et al., 2001).binding. However, based on our structure determina-
tion, there is no region of this size in AvrPphF ORF2 The virulence function of type III effectors is thought
to result from their activity on one or more host targets,which is not folded into the structure described pre-
viously. We have been able to demonstrate interaction altering host cell defense or physiology to favor survival
of the pathogen. Correspondingly, mutations that dis-of AvrPphF ORF1 and ORF2 in vitro (data not shown) and
can isolate such complexes on gel filtration columns. rupt a type III effector’s ability to trigger specific plant
immune response should also disrupt virulence func-Structure determination of these complexes will allow us
to answer unresolved questions about the mechanism of tion. This mechanistic scenario also posits that the result
of the type III effector’s virulence activity is the signalinteraction of this chaperone-effector pair.
The structure of the type III effector AvrPphF ORF2 for specific plant disease resistance gene function (Dangl
and Jones, 2001; Van der Biezen and Jones, 1998). Sev-forms a new fold that structurally resembles a mushroom
and can be subdivided into head and stalk subdomains. eral recent studies support this hypothesis. Mutating the
catalytic triad of the cysteine protease type III effectorThe stalk subdomain does not share significant struc-
tural similarity to known structures, whereas the head AvrPphB abolishes the hypersensitive response in resis-
tant plant cultivars (Shao et al., 2002). Likewise, catalyticsubdomain shares structural similarity to the catalytic
domain of various ADP-RT toxins. However, we did not triad mutants of the predicted cysteine protease AvrRpt2
compromise its ability to elicit RPS2-dependent defensedetect any ADP-RT activity, NAD binding, or NAD glyco-
hydrolase activity associated with AvrPphF ORF2. Addi- responses (Axtell et al., 2003). In accordance with this
model, we observed that mutations decreasing the viru-tionally, function could not be assigned using sequence-
based searches such as PSI-BLAST, various threading lence of AvrPphF ORF2 on a susceptible cultivar (Ten-
dergreen) also allowed P. syringae to grow better on aalgorithms (e.g., 3D-PSSM [Kelley et al., 2000]), or the
direct three-dimensional comparison of protein folds resistant cultivar (Red Mexican) (Figure 6), presumably
by evading an immune response dependent on the viru-(e.g., DALI) or spatial patterns of residues (i.e., PINTS
[Stark et al., 2003]). It remains possible that AvrPphF lence function of AvrPphF ORF2. However, the biochem-
ical function of AvrPphF ORF2 remains elusive.ORF2 acts by binding and not by catalysis.
Despite the lack of ADP-RT activity, we used the struc- Part of the problem in assigning function from the
structure of virulence factors is that pathogenic bacteriatural similarity between AvrPphF ORF2 and diphtheria
toxin to predict amino acids important for the virulence have evolved proteins that interact with eukaryotic tar-
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pended in a buffer containing 20 mM HEPES (pH 7.5), 50 mM NaCl,gets, and in doing so they may have generated folds
and 1 mM DTT, lysed and clarified as before, and added to a 5 mlwhich differ considerably from their mammalian func-
High Trap glutathione column (Amersham Biosciences). The columntional counterparts. As an example, Salmonella sp. pro-
was then washed with 10 column volumes of buffer, followed by 5
duce a type III effector, SopE, that acts as an exchange column volumes of this buffer plus 10 mM glutathione to elute the
factor for mammalian Rho family GTPases. The SopE protein. N-terminal histidine and GST tags were removed by the
addition of TEV (tobacco etch virus) protease produced and purifiedfold is very different from the metazoan Dbl homology
in-house while dialyzing the proteins overnight in low-salt bufferdomain serving the same function (Buchwald et al.,
containing 20 mM Tris (pH 8.0). Following confirmation of complete2002).
removal of all tags by SDS-PAGE, dialysates were loaded onto anOverall, our results demonstrate that functionally im-
8 ml Source S (Amersham Biosciences) cation exchange column
portant domains of type III effectors with unknown enzy- and eluted with a gradient of NaCl. Appropriate fractions were sub-
matic function can be predicted from their three-dimen- sequently applied to a HighPrep 26/20 Sephacryl S200 (Pharmacia)
column equilibrated with 20 mM HEPES (pH 7.5), 150 mM NaCl.sional structure. The novelty of the AvrPphF ORF2 structure
This last step provided minimal increases in protein purity and con-predicts that the outcome of a large-scale structural
firmed the dimeric and monomeric nature of AvrPphF ORF1 andstudy of type III effectors from P. syringae will likely
ORF2, respectively. This column was also used to confirm the mobil-reveal many novel structures adopted to interact with
ity of mutant AvrPphF ORF2 proteins as shown in Figure 6D. Purified
eukaryotic host targets. However, as demonstrated by protein was concentrated to 10–12 mg ml1, flash-frozen using liquid
our structure-based functional analyses of AvrPphF N2, and stored at80C. AvrPphF ORF2 purified using either initially
His-tagged or GST-tagged systems was found to be folded identi-ORF2 and the recently published crystal structure of the
cally by circular dichroism (data not shown; see below).Pseudomonas syringae effector AvrB (Lee et al., 2004),
Circular dichroism experiments were run on a Pistar-180 Circularthe novelty of effector folds may also pose challenges for
Dichroism/Fluorescence spectrometer (Applied Photophysics). Sam-attribution of biochemical functions to these proteins.
ples (with protein concentrations between 0.07 and 0.21 mg/ml)
were placed in a 0.1 cm cuvette, and scans were taken from 185 to
Experimental Procedures 260 nm with 0.2 nm increments and 30,000 repetitions per increment.
Cloning of AvrPphF ORF1 and ORF2 Crystallization
For bacterial expression as N-terminally histidine-tagged proteins, Conditions for crystallization of AvrPphF ORF1 and AvrPphF ORF2
AvrPphF ORF1 and AvrPphF ORF2 were amplified by PCR from Pph were found by screening on 96-well plates using a Gilson C-240
race 7 cells and cloned into pProEX-HTa (Invitrogen) digested with workstation and commercially available (Hampton Research; Emer-
NcoI and EcoRI. To add an N-terminal GST tag, AvrPphF ORF2 ald Biostructures) and hand-made screens. Final conditions for the
was amplified by PCR using oligonucleotides that incorporated an crystallization of AvrPphF ORF1 were obtained by vapor diffusion
N-terminal TEV cleavage site and subcloned into pENTR D-TOPO of a 1:1 mix of protein (12 mg/ml) with well solution (80 mM Tris [pH
vector (Invitrogen). The gene was then recombined into pDEST-15 7.5] and 1.4–2.0 M (NH4)2SO4) at 4C. Single crystals grew in 3–5
vector using the LR Clonase enzyme mix according to manufac- days and had a modified tetrahedral morphology 200–400 m in
turer’s instructions (Invitrogen). For AvrPphF ORF1, the sequence length. Crystals were orthorhombic (P212121, a  93.1 A˚, b  94.9 A˚,
of two independent clones indicated an insertion of a single adenine and c  104.4 A˚) and could be cryoprotected by soaking in well
at position 369 relative to its NCBI database entry (AF231453). This solution containing 25% v/v glycerol for short periods of time (30 s
insertion alters and shortens the C-terminal amino acid sequence or less).
to VKKTFGFV from the reported VKKRLDLSESSV. The observed Crystals of AvrPphF ORF2 were also grown using vapor diffusion
insertion of adenine was confirmed in the sequences of two indepen- of a 1:1 mixture of protein (10 mg/ml) with well solution. However,
dent PCR products generated using a proofreading enzyme. These two different conditions (well solutions) could be used, namely 16%
data strongly indicated that the original sequence of AvrPphF ORF1 PEG8000, 150 mM Mg acetate, 80 mM Bis-Tris (pH 6.5), and 15%
as deposited carries a sequencing error. For AvrPphF ORF2 cloning, glycerol, and 1.5 M (NH4)2SO4, 2% PEG400, 80 mM HEPES (pH
the reverse PCR primer incorporated an in-frame HA-epitope coding 7.5), and 20% glycerol. Crystals grown under either condition were
sequence onto the C-terminal end of avrPphF, followed by a stop orthorhombic (P212121) with similar cell dimensions (see below), dif-
codon and a BamHI site. The resulting PCR product was cloned fracted to as high as 2 A˚ resolution, and were of similar quality.
into Topo pCR2.1 (Invitrogen) and sequenced. For AvrPphF ORF2, Both crystallization conditions are inherently cryoprotective.
the sequence of two independent clones was identical to its NCBI
database entry (AF231453). The AvrPphF-HA construct was then Structure Determination
cloned as an XbaI-BamHI fragment into the pDSK600 vector. For AvrPphF ORF1, diffraction data were collected at the SER-CAT
beamline (ID-22; Advanced Photon Source) using a single crystal
containing selenomethionine-substituted protein (Doublie, 1997).Protein Expression and Purification
AvrPphF ORF1 and ORF2 in pProEX-HTa were induced with 0.75 Phases were determined using MAD. The program SOLVE (Terwil-
liger and Berendzen, 1999) was used to find 12 selenium atomsmM IPTG at 18C for 10 hr in E. coli BL21 Codon Plus RIL cells
(Stratagene). For selenomethionine substitution, protein expression in the asymmetric unit (3 per monomer, 2 chaperone dimers per
asymmetric unit). Solvent-flattened maps calculated by DM (CCP4,was induced in the methionine auxotrophic E. coli strain B831 DE3
(Novagen) grown in 2 liters of minimal medium containing 100 mg 1994) were traced for one monomer using the program O (Jones and
Kjeldgaard, 1997) followed by the application of noncrystallographicl1 selenomethionine (Acros). Protein purification of AvrPphF ORF1
and AvrPphF ORF2 followed similar protocols. Cell pellets were symmetry to place the remaining monomers. Refinement was car-
ried out with CNS while applying restrained 4-fold noncrystallo-resuspended in buffer A (20 mM sodium phosphate [pH 7.5], 10 mM
imidazole, 150 mM NaCl, and 10% glycerol) and lysed using an graphic symmetry (Brunger et al., 1998). In the final model, the final
2 residues are missing in all four molecules. The final model containsAvestin Emulsiflex-C5, and clarified lysates were added to 5 ml High
Trap chelating columns (Amersham Biosciences) preloaded with 4276 atoms, including 1 sulfate ion per monomer and a Gly-Ala
dipeptide cloning artifact at the N terminus of each monomer. Duenickel according to the manufacturer’s instructions. Columns were
washed with several volumes of buffer A augmented with 10–50 to the low resolution, no water molecules were included in the model
(see Table 1 for X-ray data collection and refinement statistics).mM imidazole followed by specific elution of the histidine-tagged
proteins with buffer A plus 400 mM imidazole. AvrPphF ORF2 pro- For AvrPphF ORF2, data were collected on a Rigaku RU-H3R
rotating anode generator equipped with Osmic confocal “blue” op-teins (wild-type and mutant) were also expressed in E. coli and
isolated as GST fusion proteins with a TEV cleavage site between tics, and diffraction intensities were recorded on an R-Axis IV
image plate system. The structure was solved by the solvent heavy-the GST and cloned protein. Cell pellets in this case were resus-
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atom method (using cesium) of MIRAS (Dauter et al., 2000, 2001). The References
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Accession Numbers
AvrPphF ORF1 and ORF2 have been deposited in the Protein Data
Bank with accession codes 1S28 and 1S21, respectively.
Note Added in Proof
A unification of nomenclature for type III effector proteins and their
chaperones has recently been defined (M. Lindeberg et. al., sub-
mitted). AvrPphF and related proteins from various P. syringae pa-
thovars are members of the newly designated HopF2 family, and
the AvrPphF ORF1 chaperone will be termed ShcF.
